Anteris Technologies
Angela McGonagle is a Clinical Program Manager for Structural Heart Field Clinical Affairs at Anteris Technologies, having joined the company in January 2024. Previously, Angela held the position of Principal Therapy Development Specialist in Structural Heart at Medtronic from December 2020 to January 2024. Prior to that, Angela worked as a Senior Field Clinical Engineer and in Clinical Operations at Abbott from February 2018 to July 2020, and served as a Senior Field Clinical Specialist and Trainer at BIOTRONIK between February 2011 and February 2018. Angela's career began at QinetiQ North America as a Business Development Manager focused on Government Relations from October 2008 to May 2010, and included a role as a Research Engineer at Massachusetts General Hospital, where responsibilities involved managing orthopaedic research projects. Angela McGonagle earned a Bachelor of Science degree in Mechanical Engineering from Syracuse University in 2006.
This person is not in any teams
This person is not in any offices
Anteris Technologies
1 followers
Anteris Technologies is a structural heart company focused on developing innovative solutions to the biggest challenges facing aortic stenosis patients and their physicians. Our DurAVR™ Transcatheter Heart Valve (THV) System is designed for younger patients who need a heart valve that will last their lifetime. DurAVR™ THV is a unique, single-piece valve and its first-in-class biomimetic design replicates the normal blood flow of a healthy human aortic valve. | $AVR | ASX: AVR | #DurAVR #ADAPT #structuralheart #TAVR #TAVI #cardiology